金吾财讯 | 乐普生物-B(02157)公告,公司拥有人应占年内亏损4.11亿元(人民币,下同),同比增长1761.77%,每股基本亏损0.24元。董事会不建议派付末期股息。期内,收入3.68亿元,同比增长63.21%。集团就普佑恒®(普特利单抗注射液)销售录得收入3亿元,约为2023年录得收入(约1.01亿元)的三倍;集团录得CMG901许可收入约2200万元,主要来自里程碑付款;集团就提供...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.